首页> 外文期刊>Journal of Inorganic Biochemistry: An Interdisciplinary Journal >Speciation of potential anti-diabetic vanadium complexes in real serum samples
【24h】

Speciation of potential anti-diabetic vanadium complexes in real serum samples

机译:实际血清样品中潜在的抗糖尿病钒络合物的形态

获取原文
获取原文并翻译 | 示例
       

摘要

In this work the speciation in real serum samples of five (VO)-O-IV complexes with potential application in the therapy of diabetes was studied through EPR spectroscopy as a function of V concentration (45.4, 90.9 and 454.5 mu M) and time (0-180 min). [VO(dhp)(2)], [VO(ma)(2)], [VO(acac)(2)], [VO(pic)(2)(H2O)], and [VO(mepic)(2)], where Hdhp indicates 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone, Hma maltol, Hacac acetylacetone, Hpic picolinic acid, and Hmepic 6-methylpicolinic acid, were examined. The distribution of (VO2+)-O-IV among the serum bioligands was calculated from the thermodynamic stability constants in the literature and compared with the experimental results. EPR results, which confirm the prediction, depend on the strength of the ligand L and geometry assumed by the bis-chelated species at physiological pH, cis-octahedral or square pyramidal. With dhp, the strongest chelator, the system is dominated by [VO(dhp)(2)] and/or cis-VO(dhp)(2)(Protein); with intermediate strength chelators, i.e. maltolate, acetylacetonate and picolinate, by cis-VO(ma)(2)(Protein), [VO(acac)(2)] or [VO (Pic)(citrH(-1))](3-) /[VO(pic)(lactH(-1))](-) (citr = citrate and lact = lactate) when the V concentration overcomes 100-200 mu M and by (VO)(hTf)/(VO)(2)(hTf) when concentration is lower than 100 mu M; with the weakest chelator, 6-methylpicolinate, (VO)(hTf)/(VO)(2)(hTf), (VO)(HSA) (hTf = human serum transferrin and HSA = human serum albumin), and VO(mepic)(Protein)(OH) are the major species at concentration higher than 100-200 whereas hydrolytic processes are observed for lower concentrations. For [VO(dhp)(2)], [VO(ma)(2)], [VO(acac)(2)] and [VO(pic)(2)(H2O)], the EPR spectra remain unaltered with elapsing time, while for mepic they change significantly because the hydrolyzed (VO)-O-IV species are complexed by the serum bioligands, in particular by lactate. The rate of oxidation in the serum is [VO(dhp)(2)] > [VO(ma)(2)] > [VO(acac)(2)] and reflects the order of E-1/2 values.
机译:在这项工作中,通过EPR光谱学通过EPR光谱研究了五(VO)-O-IV络合物的5(VO)-O-IV络合物的潜在应用,作为糖尿病治疗的潜在应用,作为V浓度(45.4,90.9和454.5μm)和时间( 0-180分钟)。 [VO(DHP)(2)],[VO(MA)(2)],[VO(ACAC)(2)],[VO(PIC)(2)(2)(H2O)]和[VO(MEPIC)( 2)],其中HDHP表示1,2-二甲基-3-羟基-4(1H) - 吡啶酮,HMA麦芽糖醇,Hacac乙酰丙酮,HPIC吡啶酸和HMEPIC 6-甲基哌啶酸。从文献中的热力学稳定性常数计算血清Bioligands中的(VO2 +) - O-IV的分布并与实验结果相比。确认预测的EPR结果取决于在生理pH,顺式八面体或方形锥体上由双螯合物种假定的配体L和几何的强度。使用DHP,最强的螯合剂,该系统由[VO(DHP)(2)]和/或CIS-VO(DHP)(2)(2)(蛋白质)为主;中间强度螯合剂,即通过顺式-VO(MA)(2)(2)(2)(2),[VO(ACAC)(2)]或[VO(PIC)(CITRH(-1))]( 3-)/ [VO(PIC)(LACTH(-1))]( - )(Citr =柠檬酸盐和Lact =乳酸)当V浓度克服100-200μm和(VO)/(vo) )(2)(HTF)浓度低于100亩;用最弱的螯合剂,6-甲基吡啶鎓,(VO)(HTF)/(VO)(2)(HTF),(VO)(HSA)(HTF =人血清转移素和HSA =人血清白蛋白)和VO(MEPIC )(蛋白质)(OH)浓度高于100-200的主要物种,而较低浓度观察水解过程。对于[VO(DHP)(2)],[VO(MA)(2)],[VO(ACAC)(2)]和[VO(PIC)(2)(2)(H2O)],EPR光谱保持不变经过时间,而对于MEPIC,它们变化显着,因为水解的(VO)-O-IV物种由血清Bioligands浓缩,特别是通过乳酸酯。血清中的氧化速率是[VO(DHP)(2)]> [VO(MA)(2)]> [VO(ACAC)(2)],反映E-1/2值的顺序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号